October 14, 2026

EXO|E and radiofrequency (RF) microneedling are two technologies attracting attention in professional aesthetics for their potential roles in skin rejuvenation. RF microneedling uses controlled radiofrequency energy to stimulate skin remodelling, whilst EXO|E is a plant-based exosome technology developed for professional aesthetic applications.

Although these technologies work differently, they may be considered as part of a broader skin rejuvenation treatment plan. Understanding their mechanisms, potential benefits and safety requirements helps aesthetic professionals determine when each approach may be appropriate.

For aesthetic clinics in Singapore, evaluating EXO|E alongside RF microneedling requires an understanding of product-specific evidence, treatment compatibility and the importance of individualised skincare protocols.

Exosome technology is attracting increasing interest in aesthetic skincare, particularly in research exploring skin rejuvenation, cellular communication and advanced bioactive formulations. As this field develops, two approaches frequently discussed are plant-based exosomes and traditional exosome treatments.

Although both approaches involve extracellular vesicle technology, they can differ in biological source, molecular composition, manufacturing methods and intended applications. Understanding these differences is important for aesthetic practitioners evaluating emerging skincare technologies and for clinics looking to make informed decisions about professional treatment options.

For aesthetic clinics in Singapore, understanding plant-based exosomes can help practitioners evaluate new skincare technologies and determine how they may fit into professional treatment protocols.

For aesthetic clinics in Singapore, the key is to distinguish between the science behind extracellular vesicles, the formulation of individual products and the clinical evidence supporting their use.

In this guide, we compare plant-based exosome technology with traditional exosome treatments, explore their potential applications in skin rejuvenation and explain what practitioners should consider when evaluating products such as EXO|E by AG Aesthetics.

The aesthetics industry is increasingly exploring treatments that focus on skin quality, gradual rejuvenation and maintaining a healthy-looking complexion over time. Among the emerging technologies attracting attention are plant-based exosomes, which are being investigated for their potential role in cellular communication, skin repair and skin rejuvenation.

Unlike conventional skincare ingredients that primarily focus on hydration, exfoliation or surface-level improvements, exosome technology explores how biological materials may communicate with cells and influence cellular processes. However, the effectiveness of an exosome-based formulation depends on its source, composition, stability, delivery method and supporting clinical evidence.

For aesthetic clinics in Singapore, understanding plant-based exosomes can help practitioners evaluate new skincare technologies and determine how they may fit into professional treatment protocols.

In this guide, we explain what plant-based exosomes are, how they differ from conventional skincare ingredients, their potential benefits for skin rejuvenation and what to consider when choosing an exosome-based aesthetic formulation such as EXO|E.

EXO|E plant-based exosome technology is designed to support skin revitalisation by combining plant-based secretory factors, liposomes, growth factors and anti-stressing components within a professional skincare formulation. Its intended role is to complement aesthetic treatments and support visible skin-quality goals.

To understand how EXO|E works, it is important to distinguish between the broader science of plant-derived extracellular vesicles and the specific formulation used in EXO|E. Although plant-derived vesicles are being investigated for their potential roles in cellular communication and skin health, the effects of an individual product depend on its ingredients, formulation and supporting clinical evidence.